Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Published online before print July 24, 2007, 10.1148/radiol.2443061518
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2443061518v1
244/3/791    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Verma, S. K.
Right arrow Articles by Choi, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Verma, S. K.
Right arrow Articles by Choi, D.
(Radiology 2007;244:791-796.)
© RSNA, 2007

Gastrointestinal Imaging

The Cisterna Chyli: Enhancement on Delayed Phase MR Images after Intravenous Administration of Gadolinium Chelate1

Sachit K. Verma, MD 2, Donald G. Mitchell, MD, Diane Bergin, MD, Rashi Mehta, MD, Sheetal Chopra, MD, and Dongil Choi, MD, PhD 3

1 From the Department of Radiology, Thomas Jefferson University Hospital, 132 S 10th St, 1094 Main Bldg, Philadelphia, PA 19107. Received September 1, 2006; revision requested October 27; revision received November 9; accepted December 18; final version accepted February 1, 2007. Address correspondence to D.G.M. (e-mail: donald.mitchell{at}jefferson.edu).

Purpose: To retrospectively evaluate cisterna chyli (CC) enhancement on magnetic resonance (MR) images obtained after intravenous administration of a gadolinium-based contrast agent.

Materials and Methods: This retrospective HIPAA-compliant study of 1.5-T MR imaging findings was institutional review board approved; informed patient consent was waived. All MR examinations involved the acquisition of heavily T2-weighted single-shot fast spin-echo (SSFSE) images and three-dimensional (3D) gradient-echo images obtained before and during the arterial, venous, and 3–5-minute delayed phases after intravenous bolus injection of gadopentetate dimeglumine. Included were the data of 59 patients (37 men, 22 women; mean age, 59 years) who had a CC 4 mm or greater in transverse diameter, which was identified as a tubular structure with fluid signal intensity (SI) on SSFSE images. The SI of the CC relative to the spinal canal (SC) was noted and was measured on 3D gradient-echo images obtained during all phases. The Student t test was performed for statistical evaluations.

Results: Mean CC-SC SI ratios on nonenhanced, arterial phase, venous phase, and delayed phase images were 0.92, 0.98, 0.99, and 2.13, respectively. The CC had low SI on all 3D gradient-echo images obtained during the nonenhanced, arterial, and venous phases and high SI, similar to the azygos vein SI, on all delayed phase images. The CC-SC SI ratio during the delayed phase was significantly higher than that during the other phases (P < .001).

Conclusion: The CC has minimal or no enhancement on arterial phase and venous phase images but intense enhancement—similar to the enhancement of veins—on delayed phase images. Comparison of delayed phase images with SSFSE and venous phase images may help to distinguish the CC seen on delayed phase images from lymph nodes, the azygos vein, or esophageal varices.

© RSNA, 2007






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 2007 by the Radiological Society of North America.